HEART FAILURE (PEDIATRIC)
Clinical trials for HEART FAILURE (PEDIATRIC) explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE (PEDIATRIC) trials appear
Sign up with your email to follow new studies for HEART FAILURE (PEDIATRIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with weak hearts: long-term safety study launched
Disease control Recruiting nowThis study tests the long-term safety of finerenone, a medicine that may help the heart pump better by reducing inflammation and scarring. It is for children from birth to 18 years old with heart failure and a weak left ventricle. All participants will take finerenone along with …
Matched conditions: HEART FAILURE (PEDIATRIC)
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug trial aims to help kids with heart failure
Disease control Recruiting nowThis phase 3 study tests whether finerenone, a drug that blocks inflammation and scarring in the heart, can improve heart function in children aged 6 months to 18 years with heart failure and left ventricular systolic dysfunction. About 111 participants will receive either finere…
Matched conditions: HEART FAILURE (PEDIATRIC)
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC